The IRE website will be unavailable while we complete routine maintenance on Friday, December 17 from 8-10 am CT.
IRE favicon

Shop

Resource ID: #15020
Subject: Federal Government
Source: Los Angeles Times
Affiliation: 
Date: December 6 & 7, 1998

$0.00

Description

The series revealed that senior Food and Drug Administration officials dismissed explicit warnings of danger while racing to approve the diabetes pill Rezulin. It also disclosed that the government's top diabetes researcher was a paid consultant for the manufacturer of Rezulin while overseeing the drug's inclusion in a $150 million federal study. The reporting forced the FDA to acknowledge that at least 33 deaths were linked to Rezulin.

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   info@ire.org   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram